GCS expression is elevated in bladder cancers compared to normal bladder tissue, and high GCS expression was associated with a statistically significant reduction in survival time, possibly due to its higher expression in metastatic tumours [214]. The gene discussed is UGCG; the disease is urinary bladder cancer.